TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · no major macro event
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

68.60$ +3.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Liquidia Technologies Inc (LQDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 172 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LQDA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
3.7 4.5 3.0 3.7 4.4 2.9 3.1 8.8 54 92 133 172 451
0.6 1.0 1.8 1.5 1.6 1.4 1.5 1.3 3.2 7.1 12 12 34
3.1 3.5 1.2 2.2 2.9 1.6 1.6 7.5 51 85 121 160 417
7.4 13 9.8 9.4 12 16 7.0 6.0 9.3 17 12 17 56
11 17 20 20 20 21 30 39 40 48 47 57 193
18 30 30 29 32 38 37 45 49 65 59 75 248
-15 -26 -29 -27 -29 -36 -35 -38 1.8 20 62 86 169
1.8 2.0 2.5 2.6 3.0 4.4 4.7 5.7 6.9 6.9 6.5 6.3 27
-16 -27 -41 -28 -23 -38 -38 -42 -3.5 15 57 82 150
0.9 -2.4 0.4 3.9 7.0
-16 -27 -41 -28 -23 -38 -38 -42 -3.5 15 53 75 139
-13 -25 -38 -25 -20 -33 -33 -36 3.9 22 64 88 178

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?